Cell News and Research

RSS

Elsevier Foundation seeks grant proposals for 2010 Innovative Libraries in Developing Countries program

The Elsevier Foundation is seeking new grant proposals for the 2010 Innovative Libraries in Developing Countries program. Sponsored by Elsevier, a leading global publisher of scientific, technical and medical information, the Innovative Libraries program provides grants to library programs in the developing world for innovative systems and services that improve access to scientific, technical and medical information.

1 Jun 2010

University of California scientists identify new kinase that regulates cell proliferation, migration

Scientists at the University of California, San Diego have identified a previously unknown kinase that regulates cell proliferation, shape and migration, and may play a major role in the progression or metastasis of cancer cells.

1 Jun 2010

Commonalities between flies and humans make valuable new model for galactosemia

Galactosemia is a metabolic disease resulting from an inherited defect that prevents the proper metabolism of galactose, a sugar commonly found in dairy products, like milk. Exposure of affected people to galactose, can damage most of their organ systems and can be fatal. The ability to study the disease is limited by a lack of animal models.

1 Jun 2010

EpiCept provides update on post-approval commitments requested by EMA for Ceplene

EpiCept Corporation today provided an update on the post-approval commitments requested by the European Medicines Agency as part of its marketing authorization for Ceplene (histamine dihydrochloride). Ceplene is approved in the EU for remission maintenance and prevention of relapse in adults with Acute Myeloid Leukemia in first complete remission.

1 Jun 2010

Dendreon announces data presentation from 4 PROVENGE clinical trials at 105th AUA annual meeting

Dendreon Corporation today announced the presentation of safety data from the integrated analysis of four randomized PROVENGE® (sipuleucel-T) clinical trials of an autologous cellular immunotherapy in prostate cancer at the 105th Annual Scientific Meeting of the American Urological Association (AUA) in San Francisco.

1 Jun 2010

World No Tobacco Day observed worldwide

In a new online survey of 15,559 Internet users in China findings show that more than fifty percent smokers find it difficult to quit the habit without professional assistance. This survey came in the wake of the World No Tobacco Day observed on the 31st of May and supported by the media center of the Ministry of Health and the Life Times newspaper.

31 May 2010

Karolinska Institutet researchers produce human stem cells without using animal substances

For the first time, human embryonic stem cells have been cultured under chemically controlled conditions without the use of animal substances, which is essential for future clinical uses. The method has been developed by researchers at Karolinska Institutet and is presented in the journal Nature Biotechnology.

31 May 2010

Cook Medical launches BIGopsy Backloading Biopsy Forceps for accurate diagnosis of kidney cancers

Urologists treating patients with suspicious ureteral or kidney lesions now have a tool to help them more effectively make diagnoses. Cook Medical has introduced the BIGopsy Backloading Biopsy Forceps, a device designed and engineered to obtain large renal or ureteral tissue specimens up to 4 mm3 for cancer diagnosis. The larger sample size helps produce biopsy results without the need for repeat tissue-sampling procedures associated with other biopsy devices.

31 May 2010

Amorfix provides update on development of blood test for vCJD

Amorfix Life Sciences, a company focused on treatments and diagnostics for misfolded protein diseases, provides an update on the development of a blood test for vCJD, one of its six product development programs.

31 May 2010

U.S. Department of Defense OTT initiative to replace scars and defects with healthy, functional tissues

A two-year, $12 million contract with the U.S. Department of Defense Office of Technology Transition (OTT) will jumpstart human trials of three innovative research programs that aim to replace scars and defects with healthy, functional tissues, announced officials of the University of Pittsburgh and the McGowan Institute for Regenerative Medicine today at the Institute's Second Annual Open Session, Soldiers and Sailors Memorial Hall, Oakland.

31 May 2010

Researchers identify pattern of gene expression in kidney transplant recipients who don't need anti-rejection drugs

Researchers have identified a distinct pattern of gene expression in the largest reported group of kidney transplant recipients who have not rejected the transplant kidneys even though they stopped taking anti-rejection drugs. This finding may help identify other transplant recipients who could safely reduce or end use of immunosuppressive therapy. In 2008, more than 80,000 people in the United States were living with a kidney transplant.

31 May 2010

BioTime offers 5 new human stem cell lines developed using ACTCellerate technology for research use

BioTime, Inc. announced today that on June 1, 2010 the Company will be offering for sale five new human stem cell lines for research use only. These cell lines were developed using BioTime's ACTCellerate™ technology. These highly purified, novel, and scalable cell lines are embryonic progenitors, meaning that they are intermediate between human embryonic stem cells and fully developed cells.

31 May 2010

Scientists identify new susceptibility genes in genome-wide association study of nasopharyngeal carcinoma

Scientists from Singapore, China and USA have identified three new susceptibility genes in a genome-wide association study of nasopharyngeal carcinoma (NPC). The study, led by the Genome Institute of Singapore (GIS), a biomedical research institute of the Agency for Science, Technology and Research (A*STAR), and the Sun Yat-Sen University Cancer Centre, identified genetic risk factors of NPC that advance the understanding of the important role played by host genetic variation in influencing the susceptibility to this cancer.

31 May 2010

St. Jude Garden provides fresh produce to patients, staff

Harvesting fruits, vegetables and herbs at the peak of freshness is a recipe for good taste, but it also offers higher nutritional value which is important to the patients and staff at St. Jude Children's Research Hospital.

29 May 2010

Yeast produce a hormone that triggers fungal cells to become more infectious

In their ongoing studies of how yeast (fungi) can infect a host and cause disease, a research team at the Life Sciences and Bioengineering Center at Worcester Polytechnic Institute (WPI) has made an unexpected discovery. They found that yeast produce a hormone previously known to be made by plants, and that the presence of that hormone in sufficient quantity within the yeast's immediate environment triggers the fungal cells to become more infectious.

29 May 2010

RNA viruses hijack cellular enzyme to create viral replication factories on cell membranes

Nihal Altan-Bonnet, assistant professor of cell biology, Rutgers University in Newark, and her research team have made a significant new discovery about RNA viruses and how they replicate themselves.

29 May 2010

UC Riverside botanist receives BSA Merit Award for outstanding contributions to botanical science

Darleen DeMason, a professor of botany in UC Riverside's Department of Botany and Plant Sciences, has been elected as one of this year's six Botanical Society of America Merit Award recipients.

29 May 2010

BUYINS.NET updates coverage on MedeFile International

BUYINS.NET, http://www.buyins.net, a leading provider of Regulation SHO compliance monitoring, short sale trading statistics and market integrity surveillance, has updated coverage on MedeFile International after releasing the latest short sale data through May 27, 2010. The total aggregate number of shares shorted since August 2009 is approximately 1.75 billion shares.

29 May 2010

Patients with stage IIIA NSCLC who receive lobectomy have increased overall survival: Research

There's debate about the best treatment approach for patients with certain stages of non-small cell lung cancer, which accounts for about 80 percent of all lung cancers. Patients with early stages of NSCLC are typically treated with surgery, but those with stage IIIA present more of a challenge because they are such a diverse group.

29 May 2010

Bioheart to establish two Centers of Excellence to provide cell therapy procedures for patients with CHF, PAD

Bioheart, Inc., announced today plans for establishing two Centers of Excellence in the Middle East to provide its cell therapy procedures to patients suffering from congestive heart failure and peripheral arterial disease. Dr. Karl E. Groth, Chairman and CEO, and Peggy A. Farley, Chief Operating and Financial Officer, are now in that region holding discussions and performing site inspections.

29 May 2010

Cell News and Research

Elsevier Foundation seeks grant proposals for 2010 Innovative Libraries in Developing Countries program

University of California scientists identify new kinase that regulates cell proliferation, migration

Commonalities between flies and humans make valuable new model for galactosemia

EpiCept provides update on post-approval commitments requested by EMA for Ceplene

Dendreon announces data presentation from 4 PROVENGE clinical trials at 105th AUA annual meeting

World No Tobacco Day observed worldwide

Karolinska Institutet researchers produce human stem cells without using animal substances

Cook Medical launches BIGopsy Backloading Biopsy Forceps for accurate diagnosis of kidney cancers

Amorfix provides update on development of blood test for vCJD

U.S. Department of Defense OTT initiative to replace scars and defects with healthy, functional tissues

Researchers identify pattern of gene expression in kidney transplant recipients who don't need anti-rejection drugs

BioTime offers 5 new human stem cell lines developed using ACTCellerate technology for research use

Scientists identify new susceptibility genes in genome-wide association study of nasopharyngeal carcinoma

St. Jude Garden provides fresh produce to patients, staff

Yeast produce a hormone that triggers fungal cells to become more infectious

RNA viruses hijack cellular enzyme to create viral replication factories on cell membranes

UC Riverside botanist receives BSA Merit Award for outstanding contributions to botanical science

BUYINS.NET updates coverage on MedeFile International

Patients with stage IIIA NSCLC who receive lobectomy have increased overall survival: Research

Bioheart to establish two Centers of Excellence to provide cell therapy procedures for patients with CHF, PAD

What are the challenges of cell line development? eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics